Treatment with 7,8-DHF restored motor function deficits through the induction of TrkB and activation of extracellular signal-regulated kinase 1/2 (ERK1/2) in both the striatum and SN of the MPTP-induced C57BL/6 mouse model of PD [113]. The gene discussed is NTRK2; the disease is Parkinson disease.